ClinicalTrials.Veeva

Menu

PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon (PITUICARE-Lyon)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Unknown

Conditions

Pituitary Tumor

Study type

Observational

Funder types

Other

Identifiers

NCT02854228
69HCL16_0506

Details and patient eligibility

About

The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity through computerized collection of comprehensive demographic, therapeutic, pathologic and outcome information on patients harboring pituitary mass lesions of all types.

Enrollment

1,300 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

• patients with confirmed pituitary disease

Exclusion criteria

• patients who do not have confirmed pituitary disease

Trial contacts and locations

1

Loading...

Central trial contact

Gerald Raverot, MD PhD; Emmanuel Jouanneau, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems